Characterization of Recombinant Dengue-2 Virus Derived from a Single Nucleotide Substitution in the 5′ Noncoding Region
Open Access
- 22 March 2010
- journal article
- research article
- Published by Wiley in Journal of Biomedicine and Biotechnology
- Vol. 2010, 1-8
Abstract
Variants of wild-type dengue serotype 2 (DEN-2) virus containing nucleotide substitutions at positions 14, 15, or 57 in theNCR were constructed by PCR-mediated site-directed mutagenesis. All three viruses containing a single point substitution demonstrated attenuation phenotype as evidenced by decreases replication and plaque size in cell culture assay. All three variants were less neurovirulent in newborn mice compared to the wild type. The mutants were immunogenic in adult mice immunogenicity and maintained stable replication characteristics following passage in mice. The variant viruses were competent for replication inAedes aegypimosquito vector, albeit at lower levels of infection and dissemination in the mosquito than the wild-type Den-2 16681 virus. Although all of the viruses, including the wild type, were found transmissible in mosquito life cycles, they were found subsequentially decreased in efficiency of infection, transmission, and dissemination rates along the mosquito generations and all of them remained genetically stable.
Keywords
Funding Information
- National Center for Genetic Engineering and Biotechnology
- National Science and Technology Development Agency
This publication has 23 references indexed in Scilit:
- Substitution or deletion mutations between nt 54 and 70 in the 5′ non-coding region of dengue type 2 virus produce variable effects on virus viabilityJournal of General Virology, 2007
- A 5′ RNA element promotes dengue virus RNA synthesis on a circular genomeGenes & Development, 2006
- Determining genetic stabilities of chimeric dengue vaccine candidates based on dengue 2 PDK-53 virus by sequencing and quantitative TaqMAMAJournal of Virological Methods, 2006
- Chimeric Dengue 2 PDK-53/West Nile NY99 Viruses Retain the Phenotypic Attenuation Markers of the Candidate PDK-53 Vaccine Virus and Protect Mice against Lethal Challenge with West Nile VirusJournal of Virology, 2005
- Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine DevelopmentJournal of Virology, 2003
- Chimeric Dengue Type 2 (Vaccine Strain PDK-53)/Dengue Type 1 Virus as a Potential Candidate Dengue Type 1 Virus VaccineJournal of Virology, 2000
- Growth-Restricted Dengue Virus Mutants Containing Deletions in the 5′ Noncoding Region of the RNA GenomeVirology, 1995
- Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue cultureVirology, 1992
- The 5′ noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivityVirology, 1991
- Point mutations modify the response of poliovirus RNA to a translation initiation factor: A comparison of neurovirulent and attenuated strainsVirology, 1988